Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a… Grant US-11723951-B2 United States of America 15 Aug 2023
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a… Grant US-10722551-B2 United States of America 28 Jul 2020
Fusion proteins comprising P3 of bacteriophage Grant US-10526377-B2 United States of America 07 Jan 2020
METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES Application WO-2019154515-A1 World Intellectual Property Organisation (WIPO) 15 Aug 2019
Bacteriophage gene 3 protein compositions and use as amyloid binding agents Grant US-10151762-B2 United States of America 11 Dec 2018
Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced… Grant US-9988444-B2 United States of America 05 Jun 2018
Bacteriophage gene 3 protein compositions and use as amyloid binding agents Grant US-9688728-B2 United States of America 27 Jun 2017
NOVEL BLOOD CELL BIOMARKER FOR LATE ONSET ALZHEIMER'S DISEASE Application WO-2017040594-A1 World Intellectual Property Organisation (WIPO) 09 Mar 2017
Bacteriophage gene 3 protein compositions and use as amyloid binding agents Grant US-9493515-B2 United States of America 15 Nov 2016
Bacteriophage gene 3 protein compositions and use as amyloid binding agents Grant US-9493516-B2 United States of America 15 Nov 2016
COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE Application WO-2012166862-A1 World Intellectual Property Organisation (WIPO) 06 Dec 2012
A GNMT- knockout mouse model for depression, schiozophrenia and Alzheimer's disease Application EP-2246434-A1 European Patent Office 03 Nov 2010